From zealous drug warrior to out-of-touch elder statesman to the regulated marijuana industry’s savior apparent.
President Joe Biden’s long arc in public life might have more twists ahead.
The United Kingdom’s Home Affairs Committee is recommending the government widen access to unlicensed cannabis-based products for medical use via the National Health Service before the end of the current Parliament.
The U.S. Drug Enforcement Administration is proposing changes to federal drug-control laws that could effectively ban nearly all delta-8 THC products currently on the market and significantly upend the country’s $5 billion CBD industry, according to a presentation at a recent agency conference.
Colorado-based CBD and hemp company Charlotte’s Web Holdings and a British American Tobacco subsidiary are teaming up to seek U.S. Food and Drug Administration approval for a drug containing hemp.
In the context of a shrinking medical marijuana market, some Canadian companies are focusing on selling medical cannabis to patients whose purchases are covered by employee health benefit plans, citing improved customer retention and consistency.
A panel set up by Japan’s Ministry of Health, Labor and Welfare is recommending that the nation’s lawmakers carve out a legal pathway to import scientifically proven medical cannabinoids, similar to the approach South Korea took about four years ago.
The largest CBD companies in the U.S. experienced declining market share in the second quarter, as the return of in-person shopping triggered a decline in e-commerce sales.
Market share by revenue for the top 20 CBD brands shrank 2 percentage points, to 16%, versus the first quarter of the year, according to Chicago-based cannabis analytics firm Brightfield Group.
Six entities are registered with the DEA to cultivate marijuana for DEA-licensed researchers working on studies approved by the FDA.
U.S. health regulators are taking their closest look in more than three years at the idea of incorporating cannabinoids into dietary supplements.
Low-THC hemp extracts become illegal marijuana the moment they exceed o.3% THC, a federal appeals court ruled, dismissing a pair of lawsuits challenging a 2020 rule from the U.S. Drug Enforcement Administration.
A bill passed by the North Carolina Senate to legalize medical marijuana is likely doomed after the state House backed a competing bill that would permit cannabis products to be sold in the state only if they are approved by the U.S. Food and Drug Administration.
The cannabis industry hit a possible milestone in March when Bright Green Corp., a Florida company with “conditional” approval from the U.S. Drug Enforcement Administration to grow marijuana for research purposes, applied to list on the Nasdaq stock exchange.
But the move also highlights the lofty – some say unrealistic – financial ambitions of such companies.
